Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis.
暂无分享,去创建一个
J. Lafitte | C. Marquette | B. Wallaert | A. Tonnel | T. Perez | P. Ramon | P. Ramon | K. van Oortegem | K. V. Oortegem | T. Pérez | JJ Lafitte
[1] R. D. du Bois,et al. Prediction of disease progression in idiopathic pulmonary fibrosis. , 1994, The European respiratory journal.
[2] J. Roca,et al. Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. , 1994, The European respiratory journal.
[3] C. Vesin,et al. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. , 1994, The European respiratory journal.
[4] D. Schwartz,et al. Determinants of progression in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.
[5] J. McDougall,et al. Colchicine in the treatment of pulmonary fibrosis. , 1993, Chest.
[6] D. Schwartz,et al. Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies. , 1993, Chest.
[7] J. Roca,et al. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up. , 1992, Thorax.
[8] G. Raghu,et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.
[9] T. King,et al. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. , 1990, The American journal of medicine.
[10] B. Wallaert,et al. Superoxide anion generation by alveolar inflammatory cells in simple pneumoconiosis and in progressive massive fibrosis of nonsmoking coal workers. , 1990, The American review of respiratory disease.
[11] J. Darbyshire,et al. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. , 1989, Thorax.
[12] J. Cordier,et al. Gallium-67 scanning in the staging of cryptogenetic fibrosing alveolitis and hypersensitivity pneumonitis. , 1988, The European respiratory journal.
[13] G. Hunninghake,et al. Prognostic role of eosinophils in pulmonary fibrosis. , 1987, Chest.
[14] M. Schwarz,et al. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. , 1987, The American review of respiratory disease.
[15] M. Turner-Warwick,et al. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. , 1987, The American review of respiratory disease.
[16] A. Degraff,et al. Adverse effects of cyclophosphamide in idiopathic pulmonary fibrosis. , 1985, Connecticut medicine.
[17] E. Taskinen,et al. Prognosis of cryptogenic fibrosing alveolitis. , 1983, Thorax.
[18] R. Rudd,et al. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. , 1981, The American review of respiratory disease.
[19] A. Salsbury,et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. , 1980, Thorax.
[20] B. Burrows,et al. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.
[21] J. Allen,et al. Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. , 1978, The American journal of medicine.
[22] R G Gupta,et al. Natural history and treated course of usual and desquamative interstitial pneumonia. , 1978, The New England journal of medicine.
[23] W. Roberts,et al. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. , 1976, Annals of internal medicine.
[24] H. Kazemi,et al. Interstitial lung disease resistant to corticosteroid therapy. Report of three cases treated with azathioprine or cyclophosphamide. , 1975, Chest.